Table 5 Treatment modalities applied in patients with HCC in NCL (n = 93) and patients with HCC in LC (n = 571)
HCC in NCL | HCC in LC | ||||
|---|---|---|---|---|---|
Treatment modality | n | % | n | % | |
Curative treatment | Resection | 22 | 23.66 | 69 | 12.1 |
RFA/thermoablation | 5 | 5.38 | 27 | 4.7 | |
Liver transplantation | 1 | 1.08 | 8 | 1.4 | |
Total | 28 | 30.11 | 104 | 18.2 | |
Palliative treatment | Transarterial chemoembolization | 14 | 15.05 | 128 | 22.4 |
Systemic therapy (chemotherapy or sorafenib) | 22 | 23.66 | 167 | 29.3 | |
Y90-radioembolisation | 3 | 3.23 | 23 | 4.0 | |
HD-interstitial brachytherapy | 12 | 12.90 | 52 | 9.1 | |
Best supportive care | 5 | 5.38 | 20 | 3.5 | |
Total | 56 | 60.22 | 390 | 68.3 | |
No data | 9 | 9.68 | 77 | 13.5 | |